Preclinical Tests on Primates of Two New Vaccines from Coronavirus was held in Sochi, the candidate of biological sciences, Deputy Director for the Research Institute of the Russian Research Institute (Research Institute) of the Medical Primatology of Gina Karale-oglu.
“Primates testing two new Russian vaccines from coronavirus, which are under development. On the basis of the Institute, the introduction of vaccine drugs monkeys, with the subsequent assessment of the clinical status and the selection of blood samples in the dynamics for studying immunogenicity,” KALAL word passes -Okly, explained that information about developers and preparations is strictly confidential.
She reported that preclinical primations tests allow to determine the titer of antibodies that are produced during vaccination. This indicator determines the degree of protection of the organism against viral infection. There were no side effects after the introduction of vaccine monkeys.
According to Kararal Ogly, the serum of primates after the introduction of vaccines is directed to developers, after successful preclinical tests of new vaccines follows the clinical stage – in humans.
“Conducting experiments due to high costs and ethical norms is significantly limited. Since the monkey is a laboratory twin of a person, then the data obtained from the trim tests can be transferred to people with minimal correction. Therefore, pharmaceuticals are very important to tester on primates before carrying out clinical trials, “- summarized Karale-ogs.